Corvus Pharmaceuticals In...

NASDAQ: CRVS · Real-Time Price · USD
4.00
0.22 (5.82%)
At close: Jun 02, 2025, 3:59 PM
4.04
0.87%
After-hours: Jun 02, 2025, 07:18 PM EDT
5.82%
Bid 4
Market Cap 308.84M
Revenue (ttm) n/a
Net Income (ttm) -41.4M
EPS (ttm) -1.03
PE Ratio (ttm) -3.89
Forward PE -6.22
Analyst Buy
Ask 4.4
Volume 740,755
Avg. Volume (20D) 1,001,155
Open 3.78
Previous Close 3.78
Day's Range 3.73 - 4.01
52-Week Range 1.75 - 10.00
Beta 0.57

About CRVS

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRVS
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CRVS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
+32.24%
Corvus Pharmaceuticals shares are trading higher a... Unlock content with Pro Subscription
3 weeks ago
+4.69%
Corvus Pharmaceuticals shares are trading higher after it reported Q1 EPS. Company also reported data from its Cohorts 1-3 of Placebo-Controlled phase 1 clinical trial